NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 03:40PM ET
0.3011
Dollar change
-0.0087
Percentage change
-2.81
%
Index- P/E- EPS (ttm)-0.73 Insider Own19.35% Shs Outstand61.97M Perf Week0.37%
Market Cap18.67M Forward P/E- EPS next Y-0.28 Insider Trans0.32% Shs Float50.00M Perf Month25.98%
Enterprise Value2.71M PEG- EPS next Q-0.10 Inst Own9.13% Short Float3.08% Perf Quarter-28.45%
Income-33.30M P/S- EPS this Y52.62% Inst Trans10.61% Short Ratio1.32 Perf Half Y-60.76%
Sales0.00M P/B1.52 EPS next Y31.29% ROA-106.81% Short Interest1.54M Perf YTD-57.07%
Book/sh0.20 P/C1.14 EPS next 5Y32.88% ROE-161.93% 52W High2.54 -88.12% Perf Year-81.97%
Cash/sh0.26 P/FCF- EPS past 3/5Y-5.37% -16.44% ROIC-265.34% 52W Low0.22 35.45% Perf 3Y-83.64%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility10.32% 11.79% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM20.71% Oper. Margin- ATR (14)0.03 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.09 Sales Y/Y TTM- Profit Margin- RSI (14)49.07 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.09 EPS Q/Q49.43% SMA200.79% Beta0.87 Target Price3.25
Payout- Debt/Eq0.04 Sales Q/Q- SMA50-8.74% Rel Volume1.03 Prev Close0.31
Employees28 LT Debt/Eq0.02 EarningsMay 07 BMO SMA200-36.63% Avg Volume1.16M Price0.30
IPOOct 08, 2021 Option/ShortNo / Yes EPS/Sales Surpr.-20.69% - Trades Volume1,135,249 Change-2.81%
Date Action Analyst Rating Change Price Target Change
Dec-19-24Upgrade B. Riley Securities Neutral → Buy $1 → $1.50
Jul-30-24Downgrade Cantor Fitzgerald Overweight → Neutral
Nov-03-21Initiated Oppenheimer Outperform $22
Nov-03-21Initiated B. Riley Securities Buy $27
Today 07:30AM
Jun-25-25 07:30AM
Jun-03-25 07:30AM
May-28-25 07:30AM
May-09-25 11:31AM
07:30AM Loading…
07:30AM
May-08-25 07:30AM
May-07-25 07:30AM
Apr-01-25 07:30AM
Mar-25-25 07:30AM
Mar-21-25 03:01AM
12:18AM
Mar-20-25 01:15PM
07:00AM
Mar-14-25 08:35AM
04:05PM Loading…
Mar-13-25 04:05PM
Mar-12-25 04:05PM
01:12PM
Mar-10-25 07:30AM
Feb-27-25 07:30AM
Feb-26-25 07:00AM
Feb-25-25 07:30AM
Feb-20-25 07:30AM
Jan-30-25 07:30AM
Jan-08-25 04:14PM
Dec-20-24 07:21AM
Dec-19-24 07:31AM
Dec-18-24 07:22AM
Nov-28-24 09:55AM
Nov-26-24 07:40AM
07:30AM Loading…
07:30AM
Nov-25-24 07:30AM
Nov-15-24 08:35AM
Nov-13-24 07:30AM
Nov-12-24 08:35AM
07:30AM
Oct-31-24 04:15PM
Oct-29-24 12:55PM
Oct-23-24 07:30AM
Oct-22-24 07:30AM
Oct-09-24 05:37PM
Oct-02-24 07:30AM
Oct-01-24 07:30AM
Sep-03-24 07:30AM
Aug-22-24 07:31AM
Aug-08-24 07:00AM
Aug-05-24 07:30AM
Jul-30-24 06:32AM
Jul-29-24 11:58AM
07:00AM
Jul-26-24 04:11PM
Jul-02-24 07:30AM
May-21-24 07:30AM
May-07-24 01:53PM
07:30AM
Apr-29-24 07:30AM
Apr-22-24 07:30AM
Apr-02-24 07:30AM
Apr-01-24 07:30AM
Mar-27-24 09:31AM
01:13AM
Mar-26-24 11:53AM
07:00AM
Mar-15-24 07:30AM
Mar-14-24 04:05PM
Mar-11-24 08:16PM
04:05PM
Mar-06-24 07:30AM
Feb-26-24 07:30AM
Feb-06-24 08:47AM
Jan-04-24 07:30AM
Nov-16-23 07:30AM
Nov-15-23 07:30AM
Nov-07-23 07:30AM
Nov-03-23 06:00AM
Nov-02-23 07:30AM
Oct-27-23 07:30AM
Oct-24-23 04:30PM
Oct-16-23 07:30AM
Sep-07-23 07:45AM
Aug-30-23 08:00AM
Aug-09-23 09:09AM
Aug-08-23 09:52PM
07:00AM
Aug-02-23 07:30AM
Jul-11-23 07:30AM
Jul-05-23 07:30AM
Jun-28-23 07:00AM
Jun-27-23 07:17PM
Jun-20-23 07:30AM
Jun-02-23 07:30AM
May-23-23 09:40AM
07:30AM
May-18-23 03:53PM
07:30AM
May-04-23 04:05PM
May-01-23 07:30AM
Apr-19-23 07:30AM
Apr-12-23 07:30AM
Mar-28-23 07:30AM
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer's disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ricciardi LisaCEO & PresidentJan 31 '25Buy0.7738,85130,00138,851Feb 04 04:11 PM